3613 — Beijing Tong Ren Tang Chinese Medicine Co Balance Sheet
0.000.00%
Last trade - 00:00- HK$7.14bn
- HK$5.62bn
- HK$1.61bn
- 85
- 55
- 58
- 77
Annual balance sheet for Beijing Tong Ren Tang Chinese Medicine Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,847 | 2,276 | 2,244 | 2,379 | 1,820 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 547 | 527 | 942 | 423 | 557 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,933 | 3,277 | 3,683 | 3,844 | 3,966 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 392 | 412 | 405 | 437 | 429 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,417 | 3,835 | 4,225 | 4,434 | 4,560 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 217 | 213 | 419 | 330 | 235 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 399 | 417 | 621 | 568 | 484 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 3,017 | 3,418 | 3,604 | 3,867 | 4,075 |
| Total Liabilities & Shareholders' Equity | 3,417 | 3,835 | 4,225 | 4,434 | 4,560 |
| Total Common Shares Outstanding |